TW201542207A - 嚴重氣喘治療劑 - Google Patents

嚴重氣喘治療劑 Download PDF

Info

Publication number
TW201542207A
TW201542207A TW103134193A TW103134193A TW201542207A TW 201542207 A TW201542207 A TW 201542207A TW 103134193 A TW103134193 A TW 103134193A TW 103134193 A TW103134193 A TW 103134193A TW 201542207 A TW201542207 A TW 201542207A
Authority
TW
Taiwan
Prior art keywords
drug
treatment
tetomilast
acceptable salt
severe asthma
Prior art date
Application number
TW103134193A
Other languages
English (en)
Chinese (zh)
Inventor
Hisashi Nagamoto
Naoji Kimura
Kounori Kotosai
Keiko Karasutani
Norio Kanda
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of TW201542207A publication Critical patent/TW201542207A/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW103134193A 2013-10-03 2014-10-01 嚴重氣喘治療劑 TW201542207A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013208153 2013-10-03

Publications (1)

Publication Number Publication Date
TW201542207A true TW201542207A (zh) 2015-11-16

Family

ID=52778832

Family Applications (1)

Application Number Title Priority Date Filing Date
TW103134193A TW201542207A (zh) 2013-10-03 2014-10-01 嚴重氣喘治療劑

Country Status (3)

Country Link
AR (1) AR097886A1 (es)
TW (1) TW201542207A (es)
WO (1) WO2015050249A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1713471T1 (sl) * 2004-02-06 2012-07-31 Meda Pharma Gmbh & Co Kg Kombinacija antiholinergikov in inhibitorjev fosfodiesteraze tipa za zdravljenje respiratornih bolezni
WO2005115463A1 (en) * 2004-05-31 2005-12-08 Almirall Prodesfarma S.A. Combinations comprising antimuscarinic agents and beta-adrenergic agonists
TW200815054A (en) * 2006-06-19 2008-04-01 Otsuka Pharma Co Ltd Methods of using a thiazole derivative

Also Published As

Publication number Publication date
WO2015050249A1 (ja) 2015-04-09
AR097886A1 (es) 2016-04-20

Similar Documents

Publication Publication Date Title
JP7015331B2 (ja) ロフルミラストn-酸化物の吸入によって自己免疫、呼吸器性および炎症性の障害を処置する方法
US11975005B2 (en) Treatment of respiratory diseases
TWI468190B (zh) 具有改良之安定性的(z)-2-氰基-3-羥基-丁-2-烯酸-(4’-三氟甲基苯基)-醯胺錠劑調配物
US9078894B2 (en) Treatment of severe persistant asthma with masitinib
US20110124683A1 (en) Use of CRTH2 Antagonist Compounds
WO2007057221A2 (en) Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases
CN101883562A (zh) 包含西替利嗪以及非β-2-肾上腺素受体激动剂、β-2-肾上腺素受体激动剂或消炎药的组合物及其用于治疗呼吸疾病的用途
CN111620815B (zh) 手性氯喹、羟氯喹和其衍生物及其制备方法与用途
JP6741774B2 (ja) 慢性閉塞性肺疾患の急性増悪の治療のための投与レジメン
KR20150018526A (ko) 아베디테롤의 신규한 투약 형태 및 제형
CN108430475A (zh) 用于治疗慢性咳嗽的奥维匹坦
JP5362151B2 (ja) Pgd2拮抗剤及びヒスタミン拮抗剤からなるアレルギー性鼻炎治療用医薬
JP6741773B2 (ja) 炎症状態の急性増悪の治療のための投与レジメン
WO2012041031A1 (zh) 一种用于哮喘的吸入性复方组合物
KR20150109456A (ko) 프로토파녹사다이올 유도체 및 그의 제조방법과 용도
JP2005505560A (ja) 三環系5,6−ジヒドロ−9H−ピラゾロ(3,4−c)−1,2,4−トリアゾロ(4,3−アルファ)ピリジンを含む吸入組成物
RU2422144C2 (ru) Применение солей тиотропия для лечения тяжелых форм персистирующей астмы
TW201542207A (zh) 嚴重氣喘治療劑
AU2018314780A1 (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
JP2015505554A (ja) 咳を治療するためのpi3k阻害剤
JP6527305B2 (ja) 禁煙のためのβ−アドレナリン作動性インバースアゴニストの使用
RU2823554C1 (ru) Новые частицы носителя для сухих порошковых составов для ингаляции
JP2005206485A (ja) イソキノリンスルホンアミド誘導体を含有する医薬
WO2004087148A1 (ja) 肺疾患の治療および/または予防剤
JP2023503723A (ja) 好酸球性喘息の処置のためのmasitinibの使用